Rui Chen

Rui Chen is a Principal Bioinformatics Data Scientist at Tempus AI, starting in March 2024, focused on cancer research. Prior to Tempus, Rui served as Principal Bioinformatics Scientist at Personalis, Inc., from July 2021 to January 2024, leading developments in liquid biopsy-based cancer detection. At Roche Molecular Systems, from November 2015 to July 2021, Rui held the position of Principal Scientist II, managing interdisciplinary teams for product development and post-launch support of KAPA Target Enrichment products. Rui's earlier roles include Research Scientist and Postdoctoral Scholar at Stanford University, where projects included personalized health monitoring, and Postdoctoral Associate at Yale University, emphasizing asthma research. Rui holds a Ph.D. and M.S. in MCDB from Yale University and a Master's degree in Biochemistry and a Bachelor's degree in Biology from Fudan University.